# 119-hr-1632: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025

119-hr-1632, Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025, is a 119th Congress bill sponsored by Rep. Roy, Chip [R-TX-21] (R-TX); status introduced; PRIA reads it as touching household money (as of 2026-04-21).

- Canonical: https://policyrisk.com/legislation/119-hr-1632
- As of: 2026-04-21
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Bill: 119-hr-1632
- Congress: 119
- Title: Reciprocity Ensures Streamlined Use of Lifesaving Treatments Act of 2025
- Status: introduced
- Introduced: 2025-02-26
- Sponsor: Rep. Roy, Chip [R-TX-21] (R-TX)
- Cosponsors: 1
- Policy area: Health
- Touches household money: yes
- Last recorded action: 2026-04-21

## Summary

**Creates a pathway for U.S. approval of drugs, biologics, and devices already lawfully marketed abroad.** It would set eligibility rules, require sponsors to submit translated foreign dossiers, impose a 30-day decision clock, and allow congressional disapproval. - Patients and families: Could speed access to treatments and devices that address a public health or unmet medical need and are not currently available in the U.S. - Sponsors and manufacturers: Would file a request with English translations of foreign dossiers and pay applicable fees as if filing an application. The agency would approve or deny within 30 days and could require postmarket studies or risk-mitigation plans. - FDA and Congress: The agency may deny approvals for safety or effectiveness and must report denials monthly to congressional committees. Congress could block an approval through a joint resolution.

## Cosponsors (1)

- Rep. Harris, Andy [R-MD-1] (R-MD), 2025-02-27T00:00:00.000Z

## Provisions PRIA read

- Faster U.S. access to foreign-approved treatments: benefit, medium. If enacted, the bill would set up a fast track for some medicines and devices already sold abroad. A company could ask the FDA to recognize a drug, biologic, or device that is lawfully marketed in countries named in law or in the United Kingdom. It would only apply if the product is not already cle…

## Related bills

- 119-hr-9200: Secure the Border Act of 2026
- 119-hr-9199: Permanent Trump Secure Border Act
- 119-hr-810: Personalized Care Act of 2025
- 119-hr-21: Born-Alive Abortion Survivors Protection Act
- 119-hr-8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriations Act, 2027
- 119-hr-3228: Constitutional Hearing Protection Act

## Sources
- [119-hr-1632 on Congress.gov](https://www.congress.gov/bill/119th-congress/house-bill/1632)

## Related
- [119-hr-9200: Secure the Border Act of 2026](https://policyrisk.com/legislation/119-hr-9200)
- [119-hr-9199: Permanent Trump Secure Border Act](https://policyrisk.com/legislation/119-hr-9199)
- [119-hr-810: Personalized Care Act of 2025](https://policyrisk.com/legislation/119-hr-810)
- [119-hr-21: Born-Alive Abortion Survivors Protection Act](https://policyrisk.com/legislation/119-hr-21)
- [119-hr-8646: Agriculture, Rural Development, Food and Drug Administration, and Related Agenc…](https://policyrisk.com/legislation/119-hr-8646)
- [119-hr-3228: Constitutional Hearing Protection Act](https://policyrisk.com/legislation/119-hr-3228)
- [All bills in Congress](https://policyrisk.com/legislation)

Source: PRIA, https://policyrisk.com/legislation/119-hr-1632 (as of 2026-04-21).